We have observed
3 EP applications
Jan Albert Demolder
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
A METHOD OF TREATING BONE DISEASE
DIRECT AND SELECTIVE INHIBITION OF MDM4 FOR TREATMENT OF CANCER
IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODY AGAINST RSV PREFUSION F PROTEIN